Energetic and Safety Signatures of Type I vs Type II LRRK... | ResearchHub
Energetic and Safety Signatures of Type I vs Type II LRRK2 Kinase Inhibitors: A Quantum Biochemistry–Guided Reanalysis of Cryo-EM Structures for Parkinson’s Therapeutic Design
